Andra Ap Fonden Alnylam Pharmaceuticals, Inc. Transaction History

Andra Ap Fonden

$6.89 Billion
Q2 2025

A detailed history of Andra Ap Fonden transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Andra Ap Fonden holds 6,900 shares of ALNY stock, worth $3.15 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

6,900

Previous 16,800 58.93%

Holding current value

$3.15 Million

Previous $4.54 Million 50.4%

% of portfolio

0.03%

Previous 0.08%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 06, 2025	SELL	$224.32 - $326.09 $2.22 Million - $3.23 Million	-9,900 Reduced 58.93%	6,900 $2.25 Million
Q1 2025 May 13, 2025	SELL	$233.07 - $290.7 $2.59 Million - $3.23 Million	-11,100 Reduced 39.78%	16,800 $4.54 Million
Q4 2024 Feb 07, 2025	BUY	$232.27 - $300.43 $3.53 Million - $4.57 Million	15,200 Added 119.69%	27,900 $6.57 Million
Q3 2024 Nov 12, 2024	BUY	$233.81 - $287.01 $2.24 Million - $2.76 Million	9,600 Added 309.68%	12,700 $3.49 Million
Q2 2024 Aug 07, 2024	BUY	$143.31 - $247.0 $444,261 - $765,700	3,100 New	3,100 $753,000
Q4 2023 Feb 15, 2024	BUY	$151.41 - $196.57 $151,410 - $196,570	1,000 Added 2.9%	35,500 $6.8 Million
Q3 2023 Nov 09, 2023	SELL	$170.77 - $211.65 $1.02 Million - $1.27 Million	-6,000 Reduced 14.81%	34,500 $6.11 Million
Q2 2023 Aug 09, 2023	SELL	$185.01 - $212.05 $869,547 - $996,635	-4,700 Reduced 10.4%	40,500 $7.69 Million
Q1 2023 May 12, 2023	SELL	$182.66 - $235.53 $1.9 Million - $2.45 Million	-10,400 Reduced 18.71%	45,200 $9.05 Million
Q4 2022 Feb 13, 2023	BUY	$185.53 - $241.31 $1.3 Million - $1.69 Million	7,000 Added 14.4%	55,600 $13.2 Million
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $900,510 - $1.51 Million	6,500 Added 15.44%	48,600 $9.73 Million
Q2 2022 Aug 15, 2022	BUY	$120.42 - $169.29 $1.65 Million - $2.32 Million	13,700 Added 48.24%	42,100 $6.14 Million
Q4 2021 Feb 15, 2022	BUY	$159.56 - $209.29 $1.36 Million - $1.78 Million	8,500 Added 42.71%	28,400 $4.82 Million
Q3 2021 Nov 12, 2021	BUY	$169.75 - $207.73 $424,375 - $519,325	2,500 Added 14.37%	19,900 $3.76 Million
Q2 2021 Aug 16, 2021	BUY	$128.63 - $176.89 $180,082 - $247,645	1,400 Added 8.75%	17,400 $2.95 Million
Q1 2021 May 17, 2021	SELL	$126.83 - $175.69 $317,075 - $439,225	-2,500 Reduced 13.51%	16,000 $2.26 Million
Q4 2020 Feb 12, 2021	BUY	$122.97 - $147.0 $528,771 - $632,100	4,300 Added 30.28%	18,500 $2.4 Million
Q3 2020 Nov 12, 2020	SELL	$121.19 - $165.49 $2.9 Million - $3.96 Million	-23,900 Reduced 62.73%	14,200 $2.07 Million
Q2 2020 Aug 06, 2020	BUY	$104.21 - $156.44 $385,577 - $578,828	3,700 Added 10.76%	38,100 $5.64 Million
Q1 2020 May 13, 2020	BUY	$93.12 - $133.99 $1.86 Million - $2.68 Million	20,000 Added 138.89%	34,400 $3.74 Million
Q4 2019 Feb 10, 2020	BUY	$74.51 - $124.23 $864,316 - $1.44 Million	11,600 Added 414.29%	14,400 $1.66 Million
Q3 2019 Nov 19, 2019	BUY	$70.9 - $87.82 $198,520 - $245,895	2,800 New	2,800 $225,000
Q2 2019 Aug 15, 2019	SELL	$65.86 - $92.79 $368,816 - $519,624	-5,600 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$72.76 - $93.45 $407,456 - $523,320	5,600 New	5,600 $523,000
Q3 2018 Oct 16, 2018	SELL	$87.52 - $122.67 $1.12 Million - $1.57 Million	-12,800 Closed	0 $0
Q2 2018 Aug 17, 2018	SELL	$88.31 - $107.8 $167,789 - $204,820	-1,900 Reduced 12.93%	12,800 $1.26 Million
Q1 2018 Apr 10, 2018	BUY	$115.92 - $148.54 $1.48 Million - $1.9 Million	12,800 Added 673.68%	14,700 $1.75 Million
Q4 2017 Feb 14, 2018	BUY	$114.49 - $139.98 $217,531 - $265,962	1,900	1,900 $241,000

Others Institutions Holding ALNY

# of Institutions

808

Shares Held

115M

Call Options Held

584K

Put Options Held

648K

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $56.1B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Andra Ap Fonden with notifications on news.

Account